MOLECULAR TARGETING TECHNOLOGIES, INC.

Basic Information

833 LINCOLN AVE, UNIT 9
WEST CHESTER, PA, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 928315084
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists

    Amount: $219,935.00

    DESCRIPTION: Tracing neuronal connections with lipophilic carbocyanine dyes has revolutionized neuroanatomical tract tracing and is an essential feature to understand development of brain connections ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. A novel vaccine: botulinum neurotoxin subunit on a viral carrier.

    Amount: $2,509,160.00

    DESCRIPTION (provided by applicant): According to the NIAID fact sheet on Botulism, the extreme toxicity of botulinum neurotoxins (BoNT) and the ease of production, transport, and delivery make this ...

    STTR Phase II 2012 Department of Health and Human Services
  3. Anionic Phospholipid-Selective PET/SPECT Agent for Infection Imaging

    Amount: $224,438.00

    DESCRIPTION (provided by applicant): Although a rapid and accurate diagnosis is crucial to the management of patients suspected of bacterial infection, the currently available radiopharmaceuticals are ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Human Rabies Virus Vaccine Development

    Amount: $836,316.00

    DESCRIPTION (provided by applicant): Current human rabies virus (RV) vaccines are effective if administered in an appropriate and timely manner and therefore, RV infection is a vaccine-preventable dis ...

    STTR Phase II 2011 Department of Health and Human Services
  5. Dual Modality Labels for Macro and Micro Detection and Quantification of Stem Cel

    Amount: $196,224.00

    DESCRIPTION (provided by applicant): Stem cells hold promise for treatment of a number of disease states such as Parkinson's, Alzheimer's, spinal cord injury, diabetes, ischemia stroke and heart disea ...

    SBIR Phase I 2010 Department of Health and Human Services
  6. Superior Near-IR Dyes for Bioimaging

    Amount: $176,838.00

    DESCRIPTION (provided by applicant): Optical imaging is an advanced technique to image biotechnology products like gels, sensors, and micro arrays. It is also used increasingly to monitor specific mol ...

    SBIR Phase I 2009 Department of Health and Human Services
  7. Bright and Stable Near-IR dyes for Bioimaging

    Amount: $193,511.00

    DESCRIPTION (provided by applicant): Optical imaging is an advanced technique to image biotechnology products like gels, sensors, and micro arrays. It is also used increasingly to monitor specific mol ...

    SBIR Phase I 2009 Department of Health and Human Services
  8. Human Rabies Virus Vaccine Development

    Amount: $162,433.00

    DESCRIPTION (provided by applicant): Rabies is a major global health issue that kills approximately 40,000 to 70,000 people per year and over 10 million people who receive post-exposure prophylaxis ( ...

    STTR Phase I 2009 Department of Health and Human Services
  9. Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer

    Amount: $808,065.00

    DESCRIPTION (provided by applicant): Aggressive, invasive breast cancer will attack gt180,000 women in the US in 2007, and will take the lives of gt40,000 women. Mammograms detect lumps in breasts, H8 ...

    SBIR Phase I 2008 Department of Health and Human Services
  10. A novel vaccine: botulinum neurotoxin subunit on a viral carrier.

    Amount: $669,400.00

    DESCRIPTION (provided by applicant): According to the NIAID fact sheet on Botulism, the extreme toxicity of botulinum neurotoxins (BoNT) and the ease of production, transport, and delivery make this ...

    STTR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government